
Ibogaine Success Rate: Why One Dose Isn’t the Answer
Studies found about 23% to 55% of people treated with ibogaine for opioids were opioid-free after a year. Why one dose isn’t enough, and what a full process adds.
Call us today: (877) 876-4157

Studies found about 23% to 55% of people treated with ibogaine for opioids were opioid-free after a year. Why one dose isn’t enough, and what a full process adds.

Standard drug tests don’t look for kratom, but kratom-specific tests do. What each test checks and how long kratom and 7-OH stay in your system.

What pseudo (mitragynine pseudoindoxyl), MGM-15 and MGM-16 are, why they replaced 7-OH, where the law stands and how to get off them.

What ibogaine feels like, phase by phase: the visions, the reflection and the days after, plus how long ibogaine lasts and why doctors should be in the room.

Ibogaine is still Schedule I in the US. What the 2026 executive order, the IBOGAINE Act and new state laws change, and where treatment is legal today.

TWO VERY DIFFERENT TREATMENTS Ibogaine vs Ketamine: Which Treatment Fits Your Situation? Ibogaine vs ketamine, side by side: how each one is given, how long